Investment
Features
FeesSafety
Academy
More
Pluang+

Compare PepsiCo, Inc. (PEP) vs Smith & Nephew plc (SNN) Price & Performance

PepsiCo, Inc.Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

PepsiCo, Inc. vs Smith & Nephew plc — how do they compare? PepsiCo, Inc. trades at $126.43 (market cap $174.89B), while Smith & Nephew plc trades at $27.05 (market cap $11.10B). The key difference: PepsiCo, Inc. is far larger — about 15.8× Smith & Nephew plc's market cap, and PepsiCo, Inc. pays the higher dividend (4.61%). Which is the better fit depends on your goals — on Pluang, investors hold PepsiCo, Inc. for 107 Days and Smith & Nephew plc for 120 Days on average.

PEPSNN
Market Cap
$174.89B$11.10B
Volume
23,968,8641,051,703
Sector
Consumer StaplesHealth
52-Week High
$170.44$37.17
52-Week Low
$123.64$26.42
Typical Hold Time
107 Days120 Days
Enterprise Value
$215.61B$14.13B
Dividend Yield
4.61%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

PepsiCo, Inc.

PepsiCo (PEP) trades at $125.80, up 1.74% today, with a bearish technical signal but strong fundamentals including four consecutive quarterly EPS beats. Revenue grew to $93.93B in 2025, with a net margin of 10.78% and robust cash flow. Analyst consensus is a Buy with a $146.77 price target, though recent news highlights pricing pressures in snacks.

The outlook is mixed: strong profitability and institutional support offer upside, but bearish technicals and consumer pushback on high prices pose near-term risks. Execution on North American turnaround and margin expansion will be critical for sustained growth amid competitive and macroeconomic challenges.

Smith & Nephew plc

SNN trades at $26.89, near its 52-week low, with a bearish technical signal. Revenue and net income have grown steadily, reaching $6.16B and $625M in 2025, respectively, with improving margins. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. However, cash flow volatility and mixed analyst sentiment pose challenges.

The stock presents a value opportunity with reasonable valuation ratios (P/E 18.34, P/S 1.85), but risks include competitive pressures and recent CFO departure. Analyst consensus is cautious, with 65% hold ratings. Upside depends on execution of growth initiatives amid market headwinds.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PEP
72% Buy28% Sell
Avg holding period · 107 Days
SNN

No sentiment data available yet.

Top news

Latest headlines on both assets

About PepsiCo, Inc.

PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.

Read more on PEP →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →